OncoZenge AB (publ) (STO:ONCOZ)
Sweden · Delayed Price · Currency is SEK 7.06
+0.05 (0.71%)
Jun 11, 2026, 4:19 PM CET
OncoZenge AB Market Cap
OncoZenge AB has a market cap or net worth of 99.18 million as of June 11, 2026. Its market cap has increased by 54.51% in one year.
Market Cap
99.18M
Enterprise Value
105.74M
Revenue
71.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
7.06
Market Cap Chart
Since February 12, 2021, OncoZenge AB's market cap has increased from 89.02M to 99.18M, an increase of 11.41%. That is a compound annual growth rate of 2.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 10, 2026 | 98.48M | 15.18% |
| Dec 30, 2025 | 85.49M | 94.64% |
| Dec 30, 2024 | 43.92M | 21.36% |
| Dec 29, 2023 | 36.19M | -43.82% |
| Dec 30, 2022 | 64.42M | -52.42% |
| Dec 30, 2021 | 135.41M | 52.11% |
| Feb 12, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alligator Bioscience AB | 126.88M |
| NextCell Pharma AB | 120.30M |
| Simris Group AB (PUBL) | 116.62M |
| Biovica International AB | 105.67M |
| IRLAB Therapeutics AB | 105.32M |
| AcouSort AB | 95.87M |
| Scandinavian ChemoTech AB | 92.14M |
| Annexin Pharmaceuticals AB | 91.77M |